Venus Remedies Ltd Share Price

Q: What is the share price of Venus Remedies Ltd today?

Venus Remedies Ltd share price as on 12 Jun 2026 is ₹1774.5

Pharmaceuticals

NSE: VENUSREM Small Cap ISIN: INE411B01019

As on 13 June 2026 at 01:15 IST

₹1,774.50

+ 59.40

(3.46%)

Sell Buy

Over 1 Month

76.26%

Over 6 Months

105.80%

Over 1 Year

271.84%

Over 3 Years

635.46%

Venus Remedies Ltd Summary

Close ₹1,715.10

Open ₹1,650

High ₹1,715.10

Low ₹1,625.70

Volume 1,76,186

Net Turnover (in Cr) ₹29.97

52Wk High ₹1,736.90

52Wk Low ₹416

52Wk High / Low

416

1,736.90

Venus Remedies Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹2,292.57

EPS (TTM) 74.29

Book Value (BV) 515.92

Div. Yield 0.58 %

P/E (TTM) 23.10

Price/Book Value 3.33

Delivery % 59.12 %

Face Value 10

Key Ratios

PE Ratio 7.62

PB Ratio 0.68

EV to Sales 0.50

PEG Ratio 0.11

ROA 8.87

ROE 8.10

Debt-Equity 0.04

Net Profit Margin 6.95

Operating Profit Margin 13.94

Venus Remedies Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	668.84	613.03	565.83	608.49	567.75
Total Expenses	606.93	568.39	527.90	572.08	542.64
Profit Before Tax	71.83	44.64	37.93	36.41	48.55
Profit After Tax	45.31	28.49	26.57	40.72	61.77
Operating Profit After Depreciation	61.98	44.74	38.05	36.89	38.13

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	229.42	218.53	215.96	240.94	261.68
Total Non Current Assets	264	267.30	278.25	301.78	321.82
Total Current Assets	451.72	359.52	322.83	278.04	234.03
Total Assets	715.72	626.82	601.08	579.82	555.85
Total Shareholder's Fund	560.95	487.55	460.34	440.45	400.28

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	86.44	37.29	36.63	41.10	131.84
Net Cash Used In Investing Activities	-76.86	-8.46	-58.10	-17.25	57.34
Net Cash Used In Financing Activities	-1.02	-1.08	-0.57	-9.48	-162.24

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	660.24	586.53	547.84	585.14	532.39
Total Expenses	591.08	539.88	507.51	540.47	514.77
Profit Before Tax	79.08	46.65	40.33	44.67	41.06
Profit After Tax	52.56	30.50	28.96	48.99	54.27
Operating Profit After Depreciation	69.16	46.65	40.33	44.67	30.34

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	214.14	202.76	199.68	224.67	244.20
Total Non Current Assets	277.46	280.26	290.70	314.25	333.08
Total Current Assets	435.75	361	318.19	264.41	213.74
Total Assets	713.21	641.26	608.89	578.66	546.81
Total Shareholder's Fund	589.49	508.59	478.05	449.41	400.18

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	83.10	35.38	28.05	41	132.34
Net Cash Used In Investing Activities	-76.20	-6.94	-50.81	-16.75	55.98
Net Cash Used In Financing Activities	-	-	-	-9.13	-161.88

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	259.40	180.26	192.75	137.18	194.97
Total Expenses	195.98	142.74	161.79	121.80	165.97
Profit Before Tax	61.61	33.47	26.49	12.60	31.04
Profit After Tax	47.50	25.58	20.13	9.60	21
Operating Profit after Depreciation	68.37	40.04	32.67	18.79	35.76

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	259.01	179.95	192.65	137.13	196.74
Total Expenses	199.57	143.23	162.81	119.20	171.49
Profit Before Tax	57.57	32.81	25.60	14.70	24.84
Profit After Tax	43.45	24.92	19.24	11.69	14.79
Operating Profit after Depreciation	64.08	39.13	31.52	20.65	29.33

Venus Remedies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,655.50

S2 1,595.90

S3 1,566.10

Pivot 1,685.30

R1 1,744.90

R2 1,774.70

R3 1,834.30

Moving Average

20 SMA 1,292.24

50 SMA 1,094.15

100 SMA 933.85

200 SMA 753.74

Venus Remedies Ltd Corporate Actions

No available data

AGM Date: 20 Sep 2021

Venus Remedies Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 14 2021 to September 20 2021 (both days inclusive) for the purpose of 32nd Annual General Meeting (AGM) of the Company to be held on September 20 2021. 1. 32nd Annual General Meeting of the Company to be held on Monday, 20th September, 2021 through video conferencing('VC') / other audio visual means ('OVAM') facility in compliance with relevant circulars issued by Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI). Copy of Notice for 32nd Annual General Meeting enclosed herewith for your reference. 2. The E-voting period shall begin on Friday, September 17, 2021 at 9:00 a.m.(I.S.T) and ends on Sunday, September 19, 2021 at 5:00 p.m.(I.S.T). 3. Pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 as may be amended from time to time, the cut-off date to record the entitlement of the shareholders to cast their votes electronically (Remote e-voting) during the voting period. and during the 32nd AGM of the Company has been fixed as Monday, 13th September 2021. Outcome of Board Meeting dated 12.08.2021 as enclosed. (As per BSE Announcement Dated on 12/8/2021) Proceedings of 32nd Annual General Meeting held today i.e. 20.09.2021. (As Per BSE Announcement Dated on 9/20/2021 5:49:56 AM) Pursuant to the Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pls. find enclosed herewith Voting Results of 32nd Annual General Meeting of the Company with scrutinizer report. Venus Remedies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As per BSE Announcement Dated on 21/09/2021)

AGM Date: 23 Aug 2022

Notice of 33rd Annual General Meeting and Cut-of-date/ E-voting. Book closure for the purpose of 33rd Annual General Meeting of the Company will commence from 17th August 2022 to 23rd August 2022 (including both days). (As per BSE Announcement Dated on 29/07/2022) AGM Notice newspaper publication. (As Per BSE Announcement Dated on 30/07/2022) Proceedings of 33rd Annual General Meeting of Venus Remedies Limited, held on 23rd August 2022 (As Per BSE Announcement Dated on 23.08.2022) Declaration of Voting Results for 33rd Annual General Meeting. (As Per BSE Announcement Dated on 24.08.2022)

AGM Date: 24 Aug 2023

Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th July 2023 1. Appointment of M/s J.K. Jain & Associates as the Statutory Auditors of the Company subject to the approval of members in upcoming Annual General Meeting. The said appointment is resulting from completion of term of existing Statutory Auditors. 2. The date of 34th Annual general meeting as 24th August at 11:30 a.m. (1ST) through Video Conferencing ('VC') /Other Audio-Visual Means ('OAVM'). 3. The books closure (Register of Members and Share Transfer Books) for the purpose of 34th Annual General Meeting will commence from 18th August 2023 to 24th August 2023 (both days inclusive). 4. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on August 17, 2023. Any person, who is a member of the company as on August 17, 2023, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting period commences on August 21, 2023 (9:00 a.m.) and ends on August 23, 2023 (5 :00 p.m.). Appointment of M/s J.K. Jain & Associates as Statutory Auditors of the Company for five Financial years. (As per BSE Announcement Dated on 14/07/2023) For the purpose of 34th Annual General Meeting of the company, Book Closure will commence from 18th August 2023 to 24th August 2023( including both days). (As per BSE Announcement Dated on 22/07/2023) Proceedings of Annual General Meeting held today. (As Per BSE Announcement dated on 24.08.2023) AGM E-voting results along with scrutinizer report. (As per BSE Announcement Dated on 25/08/2023)

AGM Date: 23 Sep 2024

Details of 35th Annual general Meeting as per the Copy of notice enclosed herewith. Proceedings of 35th Annual General Meeting. (As Per BSE Announcement dated on 23.09.2024) Voting Results of 35th AGM. (As per BSE Announcement Dated on 24/09/2024)

AGM Date: 22 Aug 2025

approved as below: 1. The date of 36th Annual General Meeting fixed as 22nd August 2025 at 11:30 a.m. (1ST) through Video Conferencing ('VC') I Other Audio-Visual Means ('OAVM'). 2. The book closure (Register of Members and Share Transfer Books) for the purpose of 36th Annual General Meeting will commence from 16th August 2025 to 22nd August 2025 (both days inclusive). 3. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on 15th August 2025. Any person, who is a member of the company as on 15th August 2025, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting peri-od commences on 19th August 2025 (9:00 a.m.) and ends on 21st August 2025 (5 :00 p.m.). AGM date prior notice in Newspaper. (As Per BSE Announcement Dated on: 11.07.2025) Proceedings of 36th Annual General Meeting (As per BSE Announcement Dated on 22/08/2025)

Venus Remedies Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Venus Remedies Ltd Top Mutal Funds Invested

No data available

Venus Remedies Ltd News

Venus Remedies to convene AGM

On 20 August 2026

03 Jun 2026, 11:50 am

Board of Venus Remedies recommends final dividend

Of Rs 10 per share

27 May 2026, 11:14 am

Venus Remedies receives Saudi FDA approval for Plerixafor

22 May 2026, 03:23 pm

Venus Remedies to discuss results

On 26 May 2026

16 May 2026, 06:01 pm

Venus Remedies to hold board meeting

On 29 January 2026

19 Jan 2026, 05:41 pm

Venus Remedies Ltd Stock Analysis

Annual revenue for Venus Remedies Ltd increased by 12.57% to ₹660.24 crore in FY 2025 from ₹586.53 crore in FY 2024.
Annual Net Profit for Venus Remedies Ltd increased by 72.34% to ₹52.56 crore in FY 2025 from ₹30.50 crore in FY 2024.
Promoter Shareholding in Venus Remedies Ltd remains unchanged by 0.00% in the most recent quarter, from 41.76% in December 2025 to 41.76% in March 2026.
Venus Remedies Ltd delivered a 1-year return of 271.84% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Venus Remedies Ltd share price moved up by 3.46% from its previous close of INR ₹1,715.10. The latest Venus Remedies Ltd share price is INR ₹1,774.50.
Venus Remedies Ltd share price today has been at a low of 1,706.80 and a high of 1,799.30. Over the past 52 weeks, the Venus Remedies Ltd share price has seen a low of 416 and a high of 1,799.30.